BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8572632)

  • 1. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
    Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
    Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
    Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
    Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma.
    D'Agnano I; Cosimelli M; La Pera A; Cavaliere F; Mannella E; Giannarelli D; Cavaliere R; Zupi G
    Anticancer Res; 1993; 13(3):699-703. PubMed ID: 8317899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytometric ploidy and proliferative activity in colorectal carcinoma.
    Grigolato P; Berenzi A; Benetti A; Chirico E; Cadei M; Casella C; Salerni B; Lojacono L
    Eur J Histochem; 1994; 38(2):163-70. PubMed ID: 7524813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-cytometry DNA index of colorectal carcinomas.
    Pandrea IR; Zugun F; Târcoveanu E; Diaconu C; Mihailovici MS; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):112-5. PubMed ID: 9524666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of flow cytometric DNA analysis in colorectal cancer].
    Ando Y
    Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1700-9. PubMed ID: 2277618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
    Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
    Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric DNA analysis of malignant potential in colorectal cancer].
    Ando Y; Tsuchiya A; Oki S; Sato H; Yoshida T; Kimijima I; Abe R
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():112-7. PubMed ID: 8678552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric DNA ploidy and cell proliferative activity in colorectal adenomatous polyps.
    Wielondek M; Wilczak W; Bielicki D; Krygier-Stojałowska A; Marlicz K
    Pol J Pathol; 1998; 49(3):135-9. PubMed ID: 9810170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
    Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
    Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
    Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.